Bio Green Med Solution (BGMS) Assets Average (2011 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Assets Average of $7.9 million for Q1 2026, up 101.19% year-over-year from $3.9 million in Q1 2025, and down 3.63% quarter-over-quarter from $8.2 million in Q4 2025.
Analysis
Bio Green Med Solution (BGMS) Assets Average (2011 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Assets Average for 16 consecutive years, with $7.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 101.19% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at $7.9 million (up 101.19% YoY), while the FY2025 annual figure was $6.1 million, down 4.81% from the prior year.
- Assets Average slipped to $7.9 million in Q1 2026 per BGMS's latest filing, from $8.2 million in the prior quarter.
- Across five years, Assets Average topped out at $41.7 million in Q1 2022 and bottomed at $3.9 million in Q1 2025.
- Historically, Assets Average has averaged $15.9 million across 5 years, with a median of $8.2 million in 2025.
- Annual changes were most pronounced in 2024 — Assets Average tumbled 70.45% — and 2026, when it jumped 101.19%.
- Bio Green Med Solution's Assets Average stood at $29.8 million in 2022, then sank by 64.27% to $10.7 million in 2023, then sank by 55.52% to $4.7 million in 2024, then surged by 72.49% to $8.2 million in 2025, then decreased by 3.63% to $7.9 million in 2026.
- Business Quant data shows BGMS's Assets Average at $7.9 million in Q1 2026, $8.2 million in Q4 2025, and $6.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | 11.22 Bn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | 3.29 Bn |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 8.86 Bn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | 7.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.71 Mn |
| Mar 31, 2026 | 7.87 Mn |
| Dec 31, 2025 | 8.17 Mn |
| Sep 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 4.07 Mn |
| Mar 31, 2025 | 3.91 Mn |
| Dec 31, 2024 | 4.74 Mn |
| Sep 30, 2024 | 6.79 Mn |
| Jun 30, 2024 | 7.18 Mn |
| Mar 31, 2024 | 7.49 Mn |
| Dec 31, 2023 | 10.65 Mn |
| Sep 30, 2023 | 14.74 Mn |
| Jun 30, 2023 | 19.80 Mn |
| Mar 31, 2023 | 25.33 Mn |
| Dec 31, 2022 | 29.81 Mn |
| Sep 30, 2022 | 33.73 Mn |
| Jun 30, 2022 | 38.04 Mn |
| Mar 31, 2022 | 41.66 Mn |
| Dec 31, 2021 | 44.21 Mn |
| Sep 30, 2021 | 45.81 Mn |